← Back to search
HAWAII BIOTECH, INC.
HONOLULU, HI, 96817
UnclaimedClaim this profile (free)
Prime contracting experience
2 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF - "DEVELOPMENT OF A SMALL MOLECULE DRUG ANTI-TOXIN THERAPEUTIC TO TREAT ANTHRAX IN HUMANS." | — | $24,623,880 | Aug 6, 2026 | Sep 20, 2018 – Jul 22, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | RECOMBINANT WEST NILE VIRUS VACCINE ADJUVANTED WITH SLA-LSQ | — | $2,997,218 | Aug 2, 2022 | Jul 5, 2022 – Jul 5, 2025 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.